PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10  (10-2015)

Period of time： 2015年10期

Publisher： John Wiley & Sons Inc

Founded in： 1975

Total resources： 60

E-ISSN： 1545-5017|62|10

ISSN： 1545-5009

Subject： R Medicine and Health

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10

Menu

Issue Information

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. fi-fvii

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Expanding the WHO list of essential medicines for children: A call for further action

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. 1685-1686

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Biology of childhood acute lymphoblastic leukemia (ALL) in low/middle‐income countries—A case for using age at diagnosis for defining low‐risk all

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. 1687-1688

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Medicines for cancers in children: The WHO model for selection of essential medicines

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. 1689-1693

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Renal medullary carcinoma and sickle cell trait: A systematic review

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. 1694-1699

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle income population: A multi‐institutional report from Pakistan

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. 1700-1708

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Preclinical assessments of the MEK inhibitor PD‐0325901 in a mouse model of Neurofibromatosis type 1

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. 1709-1716

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. 1717-1724

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. 1725-1732

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Rhabdomyosarcomas in children with neurofibromatosis type I: A national historical cohort

PEDIATRIC BLOOD & CANCER (ELECTRONIC),volume 62,issue 10 , Vol. 62, Iss. 10, 2015-10 , pp. 1733-1738

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 Next Display item(s) per page Total 37 item(s)